Mayo Clinic CEO: Regulation hinders advancement of telemedicine

| | Health Exec | Precision Medicine

When the leader of a world's largest healthcare providers in the world has something to say, people tend to take notice. John Noseworthy, MD, president and CEO of Rochester, Minnesota-based Mayo Clinic, recent penned an op-ed in the Twin Cities Pioneer Press that called for regulatory advancements in the field of telemedicine. According to him, the potential of the technology is not being realized because of obstacles from outdated regulations.

"Failure to update the telemedicine regulations contradicts the growing evidence that telemedicine increases patients’ access to health care and reduces overall health care spending for the government," he wrote. "Telemedicine offers significant potential to improve patient access while reducing costs. Telemedicine delivers the right care, at the right time and in the right place—whether that place is a patient’s home or a distant clinic facility without sub-specialty care resources. The need for this sophisticated technology is not limited by geographical boundaries."

For the full op-ed, clink of the link below:

John Noseworthy: Telemedicine will increase access to care, reduce costs

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup